Usha Schick

437 total citations
20 papers, 276 citations indexed

About

Usha Schick is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Usha Schick has authored 20 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Biomedical Engineering. Recurrent topics in Usha Schick's work include Pulmonary Hypertension Research and Treatments (6 papers), Acute Myocardial Infarction Research (6 papers) and Mechanical Circulatory Support Devices (5 papers). Usha Schick is often cited by papers focused on Pulmonary Hypertension Research and Treatments (6 papers), Acute Myocardial Infarction Research (6 papers) and Mechanical Circulatory Support Devices (5 papers). Usha Schick collaborates with scholars based in Canada, United States and Germany. Usha Schick's co-authors include Richard M. Prewitt, John Ducas, Linda Girling, William Molloy, Mark Angle, Michael Schwarz, Paul Boiteau, David H. Greenberg, Stephanie Chan and R. Bruce Light and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of Applied Physiology.

In The Last Decade

Usha Schick

20 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Usha Schick Canada 9 142 113 83 75 67 20 276
A Charpentier France 11 168 1.2× 66 0.6× 165 2.0× 22 0.3× 59 0.9× 31 310
Pragnesh Joshi Australia 10 141 1.0× 92 0.8× 92 1.1× 17 0.2× 23 0.3× 35 258
J Vandenbogaerde Belgium 11 153 1.1× 65 0.6× 101 1.2× 10 0.1× 29 0.4× 20 277
Herbert J. Semler United States 11 200 1.4× 138 1.2× 80 1.0× 37 0.5× 18 0.3× 23 325
Thérèse Lognoné France 8 170 1.2× 152 1.3× 123 1.5× 25 0.3× 28 0.4× 28 270
G. Görlach Germany 9 151 1.1× 48 0.4× 122 1.5× 12 0.2× 29 0.4× 27 241
Elisabete Jorge Portugal 8 149 1.0× 54 0.5× 93 1.1× 33 0.4× 16 0.2× 44 227
Robert Brightwell United Kingdom 8 90 0.6× 123 1.1× 166 2.0× 6 0.1× 42 0.6× 15 271
Hideaki Takai Japan 14 300 2.1× 70 0.6× 113 1.4× 33 0.4× 38 0.6× 47 387
Imdad Ahmed United States 10 242 1.7× 55 0.5× 105 1.3× 63 0.8× 15 0.2× 23 330

Countries citing papers authored by Usha Schick

Since Specialization
Citations

This map shows the geographic impact of Usha Schick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Usha Schick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Usha Schick more than expected).

Fields of papers citing papers by Usha Schick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Usha Schick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Usha Schick. The network helps show where Usha Schick may publish in the future.

Co-authorship network of co-authors of Usha Schick

This figure shows the co-authorship network connecting the top 25 collaborators of Usha Schick. A scholar is included among the top collaborators of Usha Schick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Usha Schick. Usha Schick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Prewitt, Richard M., Usha Schick, & John Ducas. (1996). Optimizing Coronary Thrombolysis With IV Administration of Recombinant Tissue Plasminogen Activator. CHEST Journal. 109(2). 510–515. 2 indexed citations
4.
Prewitt, Richard M., et al.. (1995). Intravenous Administration of Recombinant Tissue Plasminogen Activator. CHEST Journal. 107(4). 1146–1151. 2 indexed citations
5.
Schick, Usha, et al.. (1995). Detection of mycobacterial DNA in a patient with neurosarcoidosis. Acta Neurologica Scandinavica. 91(4). 280–282. 6 indexed citations
6.
Prewitt, Richard M., et al.. (1994). Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. Journal of the American College of Cardiology. 23(3). 794–798. 51 indexed citations
7.
Prewitt, Richard M., et al.. (1994). Effect of Rate of Administration of Recombinant Tissue Plasminogen Activator on Efficacy of Coronary Thrombolysis. Angiology. 45(8). 687–694. 3 indexed citations
8.
Prewitt, Richard M., et al.. (1992). Dobutamine enhances recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism. Journal of Critical Care. 7(1). 1–8. 1 indexed citations
9.
Ducas, John, et al.. (1992). Pulmonary Vascular Pressure-Flow Characteristics: Effects of Dopamine before and after Pulmonary Embolism. American Review of Respiratory Disease. 146(2). 307–312. 18 indexed citations
10.
Ducas, John, et al.. (1991). Effects of left atrial pressure on the pulmonary vascular response to hypoxic ventilation. Journal of Applied Physiology. 70(5). 1991–1995. 5 indexed citations
11.
Prewitt, Richard M., et al.. (1991). Effects of flow on recombinant tissue plasminogen activator-induced pulmonary thrombolysis. Journal of Applied Physiology. 71(4). 1441–1446. 7 indexed citations
12.
Ducas, John, et al.. (1990). Pulmonary vascular pressure-flow characteristics in canine pulmonary embolism. Journal of Applied Physiology. 68(2). 462–467. 10 indexed citations
13.
Ducas, John, Usha Schick, Linda Girling, & Richard M. Prewitt. (1988). Effects of altered left atrial pressure on pulmonary vascular pressure-flow relationships. American Journal of Physiology-Heart and Circulatory Physiology. 255(1). H19–H25. 9 indexed citations
14.
Ducas, John, R. Bruce Light, Linda Girling, Usha Schick, & Richard M. Prewitt. (1988). Effects of prostaglandin E1 on the pulmonary vascular pressure-flow relationship in canine pulmonary hypertension. Journal of Critical Care. 3(1). 24–31. 4 indexed citations
15.
Boiteau, Paul, John Ducas, Usha Schick, Linda Girling, & Richard M. Prewitt. (1986). Pulmonary vascular pressure-flow relationship in canine oleic acid pulmonary edema. American Journal of Physiology-Heart and Circulatory Physiology. 251(6). H1163–H1170. 9 indexed citations
16.
Ducas, John, Linda Girling, Usha Schick, & Richard M. Prewitt. (1986). Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism.. Circulation. 73(5). 1050–1057. 30 indexed citations
17.
Ducas, John, Usha Schick, Linda Girling, & Richard M. Prewitt. (1985). Effects of reduced resistive afterload on left ventricular pressure-volume relationship. American Journal of Physiology-Heart and Circulatory Physiology. 248(2). H163–H169. 8 indexed citations
18.
Ducas, John, et al.. (1985). Acute Cardiopulmonary Effects of Nitroglycerin in Canine Oleic Acid Pulmonary Edema. Anesthesiology. 62(6). 754–758. 13 indexed citations
19.
Angle, Mark, John Ducas, Usha Schick, Linda Girling, & Richard M. Prewitt. (1984). Direct effects of nitroprusside do not alter gas exchange in canine oleic acid edema. Journal of Applied Physiology. 57(5). 1498–1501. 8 indexed citations
20.
Molloy, William, et al.. (1984). Treatment of shock in a canine model of pulmonary embolism.. PubMed. 130(5). 870–4. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026